1. FDA repeatedly adapted emergency use authorization policies to address the need for COVID-19 testing Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022 Subject(s): COVID-19 TestingDevice ApprovalGovernment RegulationUnited StatesUnited States. Food and Drug Administration